Impact of Regulatory Affairs During M&A in Life Sciences Organizations

by FMDKL

According to Bloomberg pharmaceutical industry, M&As have hit the record volume in 2015

and are valued to reach an astronomic amount of $221 billion US dollars. Life Sciences industry

has been banking on mergers and acquisitions to improve market positioning, expand product

portfolio and invest in new therapeutic areas.

Read more


Geographic Barriers – The Obstacle In Finding Cure For Rare Diseases

by FMDKL

The definition of Rare Diseases varies from country to country, but generally speaking, it can be described as a condition with low prevalence but serious life-threatening or debilitating possibilities. Global health institutes have found that there are several thousand rare disease with no cure till date.

Read more


Recommended Reading for the Medically Minded

by FMDKL
The Emperor of All Maladies, a Biography of Cancer

Cancer is one of the oldest known maladies. Imhotep, a 27th century BC Egyptian who is considered by many to be the world’s first physician, described “a bulging mass in the breast,” cool, hard, dense, and spreading insidiously under the skin. Skip forward to today and a modern day oncologist would instantly translate that description […]

Read more


Toward Eradicating Ebola

by FMDKL

The summer of 2014 will be remembered by many as the time when the Ebola virus became a global problem. Before then, Ebola was a scary disease that plagued remote African villages. An outbreak would crop up, kill anywhere from a dozen to a few hundred people, and then vanish as quickly as it appeared…

Read more